These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31611747)

  • 1. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of
    Mansour-Ghanaei F; Samadi A; Joukar F; Tirgar Fakheri H; Hassanipour S; Ashoobi MT; Soltanipour S; Alizadeh A; Rezamand G; Fathalipour M
    EXCLI J; 2019; 18():644-652. PubMed ID: 31611747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
    Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
    PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Fakheri H; Bari Z; Sardarian H
    Helicobacter; 2012 Aug; 17(4):264-8. PubMed ID: 22759325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure.
    Fakheri H; Bakhshi Z; Bari Z; Alhooei S
    Middle East J Dig Dis; 2016 Jan; 8(1):51-6. PubMed ID: 26933482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Fakheri H; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Jinghuaweikang capsules combined with furazolidone-based triple or quadruple therapy as the rescue treatment for Helicobacter pylori infection: a multicenter randomized controlled clinical trial].
    Cheng H; Hu FL; Sheng JQ; An HJ; Xu L; Liu FX; Li Y; Hao Q; Zheng PY; Lu GF; Cao ZQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(40):3206-3212. PubMed ID: 27852385
    [No Abstract]   [Full Text] [Related]  

  • 10. Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial.
    Cao Z; Chen Q; Zhang W; Liang X; Liao J; Liu W; Xiao S; Lu H
    Scand J Gastroenterol; 2015; 50(10):1185-90. PubMed ID: 25881966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
    Khatibian M; Ajvadi Y; Nasseri-Moghaddam S; Ebrahimi-Dariani N; Vahedi H; Zendehdel N; Sotoudehmanesh R; Agah S; Mikaeli J; Pourshams A; Ali-Asgari A; Malekzadeh R; Massarrat S
    Arch Iran Med; 2007 Apr; 10(2):161-7. PubMed ID: 17367217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication.
    Mokhtare M; Agah S; Fakheri H; Hosseini V; Rezaei Hemami M; Ghafoori SM
    Middle East J Dig Dis; 2015 Apr; 7(2):75-81. PubMed ID: 26106466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of
    Niu M; Zhou Y; Xie Y; Li X; Tian Y; Yao L; Li X; Gao H; Bai F
    Front Pharmacol; 2022; 13():771876. PubMed ID: 35571120
    [No Abstract]   [Full Text] [Related]  

  • 14. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
    Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
    Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
    Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
    Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients.
    Yang X; Tan P; Song L; Lu Z
    Am J Ther; 2016; 23(6):e1436-e1441. PubMed ID: 25923229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days.
    Dore MP; Farina V; Cuccu M; Mameli L; Massarelli G; Graham DY
    Helicobacter; 2011 Aug; 16(4):295-300. PubMed ID: 21762269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for
    Hajiani E; Alavinejad P; Avandi N; Masjedizadeh AR; Shayesteh AA
    Middle East J Dig Dis; 2018 Oct; 10(4):242-248. PubMed ID: 31049172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
    Choe JW; Jung SW; Kim SY; Hyun JJ; Jung YK; Koo JS; Yim HJ; Lee SW
    Helicobacter; 2018 Apr; 23(2):e12466. PubMed ID: 29369454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.